期刊文献+

乙肝病毒衣壳作为肝癌基因转移载体对肝癌是否有靶向性

Whether the hepatitis B virus envelope as a gene transfer vector has targeting ability for liver cancer
下载PDF
导出
摘要 背景与目的:乙型肝炎病毒(HBV)具有嗜肝性的主要原因在于病毒衣壳(HBVE)上镶嵌的外衣壳蛋白PreS1,利用此生物特性有可能将HBVE改造成肝癌靶向性基因转移载体.本研究探讨乙型肝炎病毒衣壳作为基因转移载体对肝癌是否有靶向性.方法:采用PEG 8000病毒浓缩法、β-丙内脂法从Hep G 2.2.15细胞上清液中制备乙型肝炎病毒衣壳(HBVE),用它包裹绿色荧光蛋白质粒(pIRS2-EGFP)后得到基因转移载体复合物HBVE-GFP,用HBVE-GFP分别转染Hep G2、A549、HeLa、FB细胞,通过荧光显微镜观察绿色荧光蛋白表达情况,通过流式细胞仪检测细胞发光率.结果:荧光显微镜下观察可见,各组均可见绿色荧光蛋白的表达,Hep G2组较之其他3组具有更高的荧光强度;流式细胞仪检测结果显示,Hep G2组的转染效率为(71.35±0.03)%,显著高于其他3组(P<0.001),且其荧光强度是其他3组的3~4倍(P<0.001).结论:乙型肝炎病毒衣壳作为载体对肝癌具有较好的靶向性. Background and purpose: The reason for hepatitis B virus (HBV) with hepatocyte specificity is PreS1 enchased on the hepatitis B virus envelope ( HBVE). So HBVE may have a potential application in liver targeting gene transfer. In this study, we investigated whether HBVE has the ability to target liver cancer cells. Methods: HBVE was obtained from the superuatant of Hep G 2.2.15 cells through PEG8000 system and β-propiolactone method. The pIRS2 -EGFP was packed with HBVE and resulted in the product HBVE-GFP. HBVE-GFP was transfected into HepG2, A549, HeLa and FB cells. The green fluorescent protein (GFP) expression was observed under a fluorescent microscope. The rate of GFP positive cells was determined by flow cytometer. Results: The GFP could be observed in the four groups, but the HepG2 group had a higher fluorescent intensity than the other 3 groups. The transfected rate of HepG2 group was ( 71.35 ± 0. 03) % , much higher than other groups( P 〈0.001) and the fluorescent intensity of the HepG2 group was also 3-4 times higher than the other 3 groups (P 〈0.001). Conclusions: The hepatitis B virus envelope (HBVE) has a good targeting ability for liver cancer cells.
出处 《中国癌症杂志》 CAS CSCD 2007年第6期433-435,共3页 China Oncology
基金 国家自然科学基金资助项目(No:30100189)
关键词 乙型肝炎病毒衣壳 靶向性 肝癌 基因转移 载体 Hepatitis B virus envelope targeting liver cancer gene transfer vector
  • 相关文献

参考文献9

  • 1Park CW,Park YM,Lee GT,el al.Targeting of therapeutic gene expression to the liver by using liver-type pyruvme kinase proximal promoter and the SV40 viral enhancer active in multiple cell types[J].Biochemi Biophy Res Commun,2004,314(1):131-137.
  • 2Park SG,Jeong YJ,Lee YY,el al.Hepatitis B virus neutralizing anti-pre-S1 hunran antibody fragments from large na? ve antibody phage library[J].Antivir Res,2005,68(3):109-115.
  • 3Wang LQ,Kaneko S,Honda M,el al.Approach to establishing a liver targeting gene therapeutic vector using naturally occurring defective hepatitis B viruses devoid of immunogenic T cell epitope[J].Virus Res.2002,85(2):187-197.
  • 4潘德键,赵忠全,王东林,陈正堂.作为基因转移载体的乙肝病毒衣壳的制备及其功能的初步鉴定[J].中国肿瘤生物治疗杂志,2006,13(5):358-361. 被引量:3
  • 5傅继华.病毒学实用实验技术[M].青岛:山东科学技术出版社,2003.102-103.
  • 6Kaneda Y,Nakajima T,Nishikawa T,el al.Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system[J].Mol Ther,2002,6(2):219-226.
  • 7Hilleman M R.Critical overview and outlook:pathogenesis,prevention,and treatment of hepatitis and hepatocarcinoma cansed by hepatitis B virus[J],Vaccine,2003,21(32):4626-4649.
  • 8Wells DJ.Gene therapy progress and prospects:electroporation and other physical methods[J].Gene Ther,2004,11(18):1363-1369.
  • 9Nguyen T H,Ferry N.Liver gene therapy:advances and hurdles[J].Gene Ther,2004;11 (Suppl 1):S76-84.

二级参考文献11

  • 1J萨姆布鲁克 EF弗里奇 T曼尼阿蒂斯著 金冬雁 黎孟枫译.分子克隆实验指南[M].北京:科学技术出版社,1999.467.
  • 2Park CW,Park YM,Lee GT,et al.Targeting of therapeutic gene expression to the liver by using liver-type pyruvate kinase proximal promoter and the SV40 viral enhancer active in multiple cell types[J].Biochem Biophys Res Commun,2004,314(1):131-137.
  • 3Park SG,Jeong YJ,Lee YY,et al.Hepatitis B virus neutralizing anti-pre-S1 human antibody fragments from large na ve antibody phage library.Antiviral Res,2005,68(3):109-115.
  • 4Wang L,Kaneko S,Honda M,et al.Approach to establishing a liver targeting gene therapeutic vector using naturally occurring defective hepatitis B viruses devoid of immunogenic T cell epitope[J].Virus Res,2002,85(2):187-197.
  • 5薛庆善.体外培养的原理及技术[M].北京:科学出版社,2001.36-40.
  • 6傅继华.病毒学实用实验技术[M].青岛:山东科学技术出版社,2003.102-103.
  • 7Kaneda Y,Nakajima T,Nishikawa T,et al.Hemagglutinating Virus of Japan (HVJ) Envelope Vector as a Versatile Gene Delivery System[J].Mol Ther,2002,6(2):219-226.
  • 8Hilleman MR.Critical overview and outlook:pathogenesis,prevention,and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus[J].Vaccine,2003,21(32):4626-4649.
  • 9Broo K,Wei J,Marshall D,et al.Viral capsid mobility:A dynamic conduit for inactivation[J].Proc Natl Acad Sci USA,2001,98(5):2274-2277.
  • 10Yamada T,Iwabuki H,Kanno T,et al.Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L(pre-S1+pre-S2+S) protein[J].Vaccine,2001,19(23-24):3154-3163.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部